Viewing StudyNCT00136409

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-05 @ 11:48 AM
Last Modification Date: 2024-10-26 @ 9:13 AM
Study NCT ID: NCT00136409
Status: COMPLETED
Last Update Posted: 2016-12-23
First Post: 2005-08-25
Brief Title: A Study of Gleevec in Patients With Idiopathic Myelofibrosis or Chronic Myelomonocytic Leukemia CMML
Sponsor: Dana-Farber Cancer Institute
Organization: Dana-Farber Cancer Institute
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Chronic Myelomonocytic Leukemia
Myelofibrosis
Myeloid Metaplasia
Agnogenic Myeloid Metaplasia
Keywords:
Name View
Gleevec View
myelofibrosis View
agnogenic myeloid metaplasia with myelofibrosis View
CMML View
chronic myelomonocytic leukemia View
imatinib mesylate View